Noticias

Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, noninferiority trial

15 Diciembre, 2017

Dr. Julián Olalla Sierra. Especialista en Medicina Interna Hospital Costa del Sol, Marbella

Accesos directos